206 related articles for article (PubMed ID: 19496630)
1. Insulin glulisine: a review of its use in the management of diabetes mellitus.
Garnock-Jones KP; Plosker GL
Drugs; 2009 May; 69(8):1035-57. PubMed ID: 19496630
[TBL] [Abstract][Full Text] [Related]
2. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
Ulrich H; Snyder B; Garg SK
Vasc Health Risk Manag; 2007; 3(3):245-54. PubMed ID: 17703632
[TBL] [Abstract][Full Text] [Related]
3. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
4. Insulin glulisine.
Robinson DM; Wellington K
Drugs; 2006; 66(6):861-9. PubMed ID: 16706558
[TBL] [Abstract][Full Text] [Related]
5. Insulin glulisine.
Cox SL
Drugs Today (Barc); 2005 Jul; 41(7):433-40. PubMed ID: 16193096
[TBL] [Abstract][Full Text] [Related]
6. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.
Danne T; Becker RH; Heise T; Bittner C; Frick AD; Rave K
Diabetes Care; 2005 Sep; 28(9):2100-5. PubMed ID: 16123473
[TBL] [Abstract][Full Text] [Related]
8. Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes.
Garg SK; Ellis SL; Ulrich H
Expert Opin Pharmacother; 2005 Apr; 6(4):643-51. PubMed ID: 15934890
[TBL] [Abstract][Full Text] [Related]
9. Insulin lispro: a review of its use in the management of diabetes mellitus.
Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.
Becker RH; Frick AD
Clin Pharmacokinet; 2008; 47(1):7-20. PubMed ID: 18076215
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
Home PD
Diabetes Obes Metab; 2012 Sep; 14(9):780-8. PubMed ID: 22321739
[TBL] [Abstract][Full Text] [Related]
12. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.
Reynolds NA; Wagstaff AJ
Drugs; 2004; 64(17):1957-74. PubMed ID: 15329046
[TBL] [Abstract][Full Text] [Related]
13. Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.
Horvath K; Bock G; Regittnig W; Bodenlenz M; Wutte A; Plank J; Magnes C; Sinner F; Fürst-Recktenwald S; Theobald K; Pieber TR
Diabetes Obes Metab; 2008 Jun; 10(6):484-91. PubMed ID: 17764465
[TBL] [Abstract][Full Text] [Related]
14. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
Luzio S; Peter R; Dunseath GJ; Mustafa L; Owens DR
Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
[TBL] [Abstract][Full Text] [Related]
15. Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
Helms KL; Kelley KW
Ann Pharmacother; 2009 Apr; 43(4):658-68. PubMed ID: 19336657
[TBL] [Abstract][Full Text] [Related]
16. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes.
Bramlage P; Tittel SR; Müther S; Reinhart-Steininger B; Haberland H; Khodaverdi S; Zimny S; Ohlenschläger U; Lanzinger S; Haak T
Acta Diabetol; 2022 Nov; 59(11):1453-1460. PubMed ID: 35933650
[TBL] [Abstract][Full Text] [Related]
18. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus.
Miles HL; Acerini CL
Paediatr Drugs; 2008; 10(3):163-76. PubMed ID: 18454569
[TBL] [Abstract][Full Text] [Related]
19. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
20. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
Wilde MI; McTavish D
Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
